In animal experiment studies, Chinese researchers have found that a metabolite of the antiviral drug Remdesivir called GS-441524 could help inhibit the severe acute respiratory syndrome coronavirus 2 ...
BOSTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced data from clinical and preclinical studies exploring the use of GS-6207, an investigational, novel, first-in-class ...
SAN DIEGO, May 20, 2014 (BUSINESS WIRE) -- Gilead Sciences, Inc. GILD +0.65% today announced results from a placebo-controlled, Phase 2a challenge study in healthy adult patients intranasally infected ...
Change Does Not Affect Ongoing “All Oral” Clinical Trials Evaluating Multiple Direct-Acting Antivirals in Combination FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today ...
The 2014 outbreak of Ebola virus, which caused more than 11,000 deaths in West Africa, has been brought to heel, but the need for effective Ebola treatments remains urgent. The drugmaker Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results